triple combination therapy

DRUG3 trials

Sponsors

The Retina Center of St. Louis County, PC, Korea University Anam Hospital, National Jewish Health

Conditions

Cystic FibrosisDiabetes Mellitus, Type IIExudative Macular Degeneration

Phase 3

Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes

Korea University Anam HospitalDiabetes Mellitus, Type II

Start: 2016-12-31End: 2019-12-31Target: 104Updated: 2016-10-27

Unknown Phase

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

CompletedNCT02287298

The Retina Center of St. Louis County, PCExudative Macular Degeneration

Start: 2014-08-31End: 2015-12-31Updated: 2016-04-06

Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.

CompletedNCT04038710

National Jewish HealthCystic Fibrosis

Start: 2019-09-05End: 2021-02-26Updated: 2021-03-11

Related Papers

Efficacy and tolerability of novel triple combination therapy in drug-naïve patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial

BMJ Open2018-09-016 citations